home       
   
 
 
  Biotecnol is a biopharmaceutical company focusing on the discovery, engineering and development of novel multifunctional antibody molecules, directed to key therapeutic targets. Using its Tribody™ technology, Biotecnol is developing a pipeline of products for applications in major disease areas such as oncology.
 
Jan 4, 2010
 
     
 
Oct 15, 2009
 
     
 
Sep 10, 2009
 
     
Type your email to receive our news :

 
   
 
Meet our delegates at the following events
Human Antibodies & Hybridomas
April 14 - 16, 2010
Porto, Portugal
Advancing Protein Therapeutics
April 21 - 22, 2010
Frankfurt, Germany
BIO 2010
May 3 - 6, 2010
Chicago, USA